{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:42:19Z","timestamp":1786538539146,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.radonc.2025.111237","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:20:56Z","timestamp":1761672056000},"page":"111237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multicenter analysis of MRI-guided, stereotactic body radiotherapy as ablative treatment for lymph nodal metastases of the abdomen and pelvis"],"prefix":"10.1016","volume":"214","author":[{"given":"Jens","family":"von der Gr\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-884X","authenticated-orcid":false,"given":"Sebastian","family":"Regnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Hoegen-Sa\u00dfmannshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Lattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Konnerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-7252","authenticated-orcid":false,"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-358X","authenticated-orcid":false,"given":"Sebastian","family":"Marschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-6446","authenticated-orcid":false,"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0005","first-page":"55","article-title":"PET\/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data","volume":"43","author":"Fanti","year":"2016","journal-title":"EJNMMI"},{"key":"10.1016\/j.radonc.2025.111237_b0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-3-26","article-title":"Follow-up of patients with curatively resected colorectal cancer: a practice guideline","volume":"3","author":"Figueredo","year":"2003","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.radonc.2025.111237_b0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.euf.2017.07.006","article-title":"Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy","volume":"3","author":"Ponti","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"2","key":"10.1016\/j.radonc.2025.111237_b0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0360-3016(01)01628-5","article-title":"Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma","volume":"51","author":"Chou","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2025.111237_b0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3126\/jnhrc.v7i2.3016","article-title":"Isolated Para-aortic lymph nodes recurrence in carcinoma cervix","volume":"7","author":"Ghimire","year":"2009","journal-title":"Journal of Nepal Health Research Council"},{"issue":"4","key":"10.1016\/j.radonc.2025.111237_b0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.oraloncology.2015.01.004","article-title":"(18)FDG-PET\/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis","volume":"51","author":"Sun","year":"2015","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.radonc.2025.111237_b0040","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00261-015-0363-6","article-title":"PET\/CT and MRI in the imaging assessment of cervical cancer","volume":"40","author":"Kusmirek","year":"2015","journal-title":"Abdom Imaging"},{"issue":"2","key":"10.1016\/j.radonc.2025.111237_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2214\/AJR.19.21177","article-title":"PET\/CT for Patients With Breast Cancer: Where Is the Clinical Impact?","volume":"213","author":"Ulaner","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.radonc.2025.111237_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13014-023-02302-8","article-title":"Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer","volume":"18","author":"Mohan","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111237_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818803597","article-title":"Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review","volume":"17","author":"Matsushita","year":"2018","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10585-020-10071-x","article-title":"Systematic review of stereotactic body radiotherapy for nodal metastases","volume":"38","author":"Deodato","year":"2021","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.radonc.2025.111237_b0070","first-page":"54","article-title":"Adaptive radiotherapy: The Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111237_b0075","first-page":"98","article-title":"Technical design and concept of a 0.35 T MR-Linac. Clin Transl","volume":"18","author":"Kl\u00fcter","year":"2019","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13014-021-01945-9","article-title":"Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience","volume":"16","author":"Garcia Sch\u00fcler","year":"2021","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2025.111237_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111237_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2019.01.024","article-title":"Feasibility of stereotactic radiotherapy using a 1.5\u00a0T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases","volume":"134","author":"Werensteijn-Honingh","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-021-01813-6","article-title":"Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis","volume":"16","author":"Mayinger","year":"2021","journal-title":"Radiation Oncology"},{"issue":"7","key":"10.1016\/j.radonc.2025.111237_b0100","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/1878-0261.12751","article-title":"Image guidance in radiation therapy for better cure of cancer","volume":"14","author":"Gr\u00e9goire","year":"2020","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00066-021-01834-w","article-title":"Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes","volume":"198","author":"Weykamp","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111237_b0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2022.04.005","article-title":"First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac","volume":"22","author":"Janssen","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"22","key":"10.1016\/j.radonc.2025.111237_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226658","article-title":"1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer","volume":"11","author":"Nicosia","year":"2022","journal-title":"JCM"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2022.05.016","article-title":"Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Abdominopelvic Oligometastases","volume":"114","author":"Yang","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111237_b0125","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2340\/1651-226X.2024.40681","article-title":"Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: a systematic review on toxicity","volume":"63","author":"Van Werkhoven","year":"2024","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal statistical society: series B (Methodological)"},{"issue":"12","key":"10.1016\/j.radonc.2025.111237_b0140","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of Hypofractionation and the Table on the Wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"4","key":"10.1016\/j.radonc.2025.111237_b0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"29","key":"10.1016\/j.radonc.2025.111237_b0155","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.22.00644","article-title":"Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials","volume":"40","author":"Deek","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111237_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110466","article-title":"Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E(2)-RADIatE OligoCare cohort","volume":"199","author":"Alongi","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2468-1253(23)00316-3","article-title":"Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.radonc.2025.111237_b0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.radonc.2025.111237_b0175","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00432-021-03739-8","article-title":"Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases","volume":"147","author":"Cuccia","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111237_b0180","doi-asserted-by":"crossref","unstructured":"Cuccia, F., et al., Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience. Medicina (Kaunas), 2023. 59(8).","DOI":"10.3390\/medicina59081442"},{"issue":"8","key":"10.1016\/j.radonc.2025.111237_b0185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00066-021-01871-5","article-title":"Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer","volume":"198","author":"Cozzi","year":"2022","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2025.111237_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1163213","article-title":"Stereotactic body radiation therapy for the treatment of lymph node metastases: a retrospective mono-institutional study in a large cohort of patients","volume":"13","author":"Caivano","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.radonc.2025.111237_b0195","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/0284186X.2021.1955970","article-title":"Progression-free survival in patients with (68)Ga-PSMA-PET-directed SBRT for lymph node oligometastases","volume":"60","author":"Werensteijn-Honingh","year":"2021","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10585-020-10047-x","article-title":"Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases","volume":"37","author":"Franzese","year":"2020","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12885-020-07033-7","article-title":"Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal\/pelvic lymph nodes: a retrospective study","volume":"20","author":"Ito","year":"2020","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.radonc.2025.111237_b0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10585-018-9922-x","article-title":"Locoregional control and survival after lymph node SBRT in oligometastatic disease","volume":"35","author":"Loi","year":"2018","journal-title":"Clin Exp Metastasis"},{"issue":"9","key":"10.1016\/j.radonc.2025.111237_b0215","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clon.2016.04.040","article-title":"Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences","volume":"28","author":"Ost","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.radonc.2025.111237_b0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/07357907.2016.1197235","article-title":"Role of Stereotactic Body Radiation Therapy with Volumetric-Modulated Arcs and High-Intensity Photon Beams for the Treatment of Abdomino-Pelvic Lymph-Node Metastases","volume":"34","author":"Franzese","year":"2016","journal-title":"Cancer Invest"},{"issue":"9","key":"10.1016\/j.radonc.2025.111237_b0225","first-page":"5103","article-title":"Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"issue":"17","key":"10.1016\/j.radonc.2025.111237_b0230","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1002\/cam4.4139","article-title":"Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis","volume":"10","author":"Yoon","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2025.111237_b0235","article-title":"Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients","volume":"10","author":"Burkon","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"issue":"10185","key":"10.1016\/j.radonc.2025.111237_b0245","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.radonc.2025.111237_b0250","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijrobp.2024.11.106","article-title":"Results of a Single-Arm Phase 2 Clinical Trial: Online Adaptive Stereotactic Body Radiation Therapy for Abdominal-Pelvic Oligometastases","volume":"122","author":"van Werkhoven","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2025.111237_b0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2025.111237_b0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0265","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijrobp.2022.07.027","article-title":"MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges","volume":"114","author":"Chetty","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13014-022-02021-6","article-title":"Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate","volume":"17","author":"Nierer","year":"2022","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2025.111237_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110235","article-title":"Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E(2)-RADIatE OligoCare study","volume":"195","author":"Christ","year":"2024","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2025.111237_b0280","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1470-2045(24)00730-7","article-title":"ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial","volume":"26","author":"Marvaso","year":"2025","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.radonc.2025.111237_b0285","first-page":"4453","article-title":"Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma","volume":"52","author":"Rofstad","year":"1992","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.radonc.2025.111237_b0290","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ijrobp.2017.08.028","article-title":"Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within \u201cRadiosensitive\u201d Subtypes","volume":"99","author":"Bernard","year":"2017","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0295","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1038\/s41598-021-90662-0","article-title":"Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy","volume":"11","author":"Corroyer-Dulmont","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.radonc.2025.111237_b0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2021.08.033","article-title":"Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer","volume":"112","author":"Henke","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2025.111237_b0305","first-page":"236","article-title":"The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?","volume":"5","author":"Thomas","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0310","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prro.2012.03.005","article-title":"Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer","volume":"3","author":"Furman","year":"2013","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111237_b0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111237_b0320","article-title":"Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E(2)-RADIatE OligoCare cohort","volume":"45","author":"Bultijnck","year":"2024","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:17:48Z","timestamp":1786537068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025052417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S0167814025052417"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111237","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter analysis of MRI-guided, stereotactic body radiotherapy as ablative treatment for lymph nodal metastases of the abdomen and pelvis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111237"}}